David Wayne Nichols

Insider Reports History

Entity
Individual
Location
C/O Magenta Therapeutics, Inc., 100 Technology Square, Cambridge, MA
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for David Wayne Nichols
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Wayne Nichols:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Chief Technical Officer Stock Option (Right to Buy) 75K Aug 1, 2022 Direct

Insider Reports Filed by David Wayne Nichols

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MGTA Magenta Therapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 1, 2022 Chief Technical Officer
MGTA Magenta Therapeutics, Inc. May 17, 2022 1 $0 4 May 19, 2022 Chief Technical Officer
MGTA Magenta Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Technical Officer
MGTA Magenta Therapeutics, Inc. Sep 16, 2021 1 -$38.3K 4 Sep 20, 2021 Chief Technical Officer
MGTA Magenta Therapeutics, Inc. Sep 14, 2021 1 $0 4 Sep 16, 2021 Chief Technical Officer
MGTA Magenta Therapeutics, Inc. Apr 19, 2021 1 $0 4/A May 17, 2021 Chief Technical Officer